tiprankstipranks

Douglas Fambrough Insider Profile

4 Followers
Douglas Fambrough, CEO, Director at Dicerna Pharma, holds 231.43K shares in Dicerna Pharma (Ticker: DRNA), holds ― shares in Oncorus (Ticker: ONCR).
tipranks
Douglas Fambrough

Douglas Fambrough
Dicerna Pharma (DRNA)
CEO, Director

Ranked #77,918 out of 98,564 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-22.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Douglas Fambrough does not currently own shares as a corporate insider.
A breakdown of Douglas Fambrough's holdings

Insider Roles

Douglas Fambrough does not currently hold a role as a corporate insider.
Roles that Douglas Fambrough holds in companies

Most Profitable Insider Trade

Stock:
Dicerna Pharma
(DRNA)
Rating:Informative Buy
Date:Sep 01, 2020 - Sep 01, 2021
Return:+13.70%
The most profitable trade made by Douglas Fambrough

Douglas Fambrough's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DRNA
Dicerna Pharma
Dec 17, 2021
Uninformative Buy
203.49K
$8.85M
ONCR
Oncorus
List of latest transactions for each holding click on a transaction to see Douglas Fambrough's performance on stock

Douglas Fambrough insider profile FAQ

What is the percentage of profitable transactions made by Douglas Fambrough?
The percentage of profitable transactions made by Douglas Fambrough is 25%.
    What is the average return per transaction made by Douglas Fambrough?
    The average return per transaction made by Douglas Fambrough is -22.50%.
      What stocks does Douglas Fambrough hold?
      Douglas Fambrough holds: DRNA, ONCR stocks.
        What was Douglas Fambrough’s latest transaction?
        Douglas Fambrough latest transaction was an Uninformative Buy of $203.49K.
          What was Douglas Fambrough's most profitable transaction?
          Douglas Fambrough’s most profitable transaction was an Informative Buy of DRNA stock on September 1, 2020. The return on the trade was 13.70%.
            What is Douglas Fambrough's role in Dicerna Pharma?
            Douglas Fambrough's role in Dicerna Pharma is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.